Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities    
Net income (loss) $ 193 $ (684)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 160 57
Share-based compensation expense 46 52
Non-cash interest expense 38 39
Amortization of debt issuance costs, deferred commitment fees, premium and discount 35 30
Loss on early extinguishment of debt 75 57
Total losses on derivatives, net 79 296
Net cash used for settlement of derivative instruments (55) (17)
Impairment expense 0 10
Other 3 9
Changes in operating assets and liabilities:    
Accounts and other receivables (63) (68)
Accounts receivable—related party (1) 0
Inventory 17 (34)
Accounts payable and accrued liabilities 45 (17)
Deferred revenue (10) (2)
Other, net (26) (23)
Net cash provided by (used in) operating activities 536 (295)
Cash flows from investing activities    
Property, plant and equipment, net (2,338) (2,277)
Investment in equity method investment (41) 0
Other 22 (22)
Net cash used in investing activities (2,357) (2,299)
Cash flows from financing activities    
Proceeds from issuances of debt 4,811 5,698
Repayments of debt (2,163) (2,893)
Debt issuance and deferred financing costs (67) (97)
Distributions and dividends to non-controlling interest (40) (40)
Payments related to tax withholdings for share-based compensation (3) (4)
Net cash provided by financing activities 2,538 2,664
Net increase in cash, cash equivalents and restricted cash 717 70
Cash, cash equivalents and restricted cash—beginning of period 1,827 1,736
Cash, cash equivalents and restricted cash—end of period $ 2,544 $ 1,806